Hepatocyte Nuclear Factor-4α Reverses Malignancy Of Hepatocellular Carcinoma Through Regulating MiR-134 In The DLK1-DIO3 Region.
Chuan Yin, Pei-qin Wang, Wen-ping Xu, Yuan Yang, Qing Zhang, Bei-fang Ning, Pingping Zhang, Weiping Zhou, Wei-Fen Xie, Wansheng Chen, Xiao-hong Zhang
Published 2013 · Biology, Medicine
Download PDFAnalyze on Scholarcy
UNLABELLED Hepatocyte nuclear factor-4α (HNF4α) is a dominant transcriptional regulator of hepatocyte differentiation and hepatocellular carcinogenesis. There is striking suppression of hepatocellular carcinoma (HCC) by HNF4α, although the mechanisms by which HNF4α reverses HCC malignancy are largely unknown. Herein, we demonstrate that HNF4α administration to HCC cells resulted in elevated levels of 28 mature microRNAs (miRNAs) from the miR-379-656 cluster, which is located in the delta-like 1 homolog (DLK1) -iodothyronine deiodinase 3 (DIO3) locus on human chromosome 14q32. Consistent with the reduction of HNF4α, these miRNAs were down-regulated in human HCC tissue. HNF4α regulated the transcription of the miR-379-656 cluster by directly binding to its response element in the DLK1-DIO3 region. Interestingly, several miRNAs in this cluster inhibited proliferation and metastasis of HCC cells in vitro. As a representative miRNA in this cluster, miR-134 exerted a dramatically suppressive effect on HCC malignancy by down-regulating the oncoprotein, KRAS. Moreover, miR-134 markedly diminished HCC tumorigenicity and displayed a significant antitumor effect in vivo. In addition, inhibition of endogenous miR-134 partially reversed the suppressive effects of HNF4α on KRAS expression and HCC malignancy. Furthermore, a positive correlation between HNF4α and miR-134 levels was observed during hepatocarcinogenesis in rats, and decreases in miR-134 levels were significantly associated with the aggressive behavior of human HCCs. CONCLUSION Our data highlight the importance of the miR-379-656 cluster in the inhibitory effect of HNF4α on HCC, and suggest that regulation of the HNF4α-miRNA cascade may have beneficial effects in the treatment of HCC.
This paper references
An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.
Maria Hatziapostolou (2011)
miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
Shuangni Yu (2010)
Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats
H-Y Yue (2009)
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
E. Jiménez-Mateos (2012)
Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene
Yunli Zhou (2010)
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
Chuan Yin (2008)
Altered MicroRNA Expression in Cervical Carcinomas
Jeong Won Lee (2008)
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Lena J. Chin (2008)
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
M. Castilla (2011)
DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
John Moon-Ching Luk (2011)
MicroRNA genes are frequently located near mouse cancer susceptibility loci
C. Sevignani (2007)
High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12.
S. Tierling (2006)
Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.
Eugene Bolotin (2010)
Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.
Pornsuk Cheunsuchon (2011)
Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region
Martin Kircher (2008)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandrés (2006)
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Venugopal Thayanithy (2012)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L. Zhang (2008)
A brain-specific microRNA regulates dendritic spine development
G. Schratt (2006)
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
F. Haller (2010)
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Linlang Guo (2010)
MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1.
Y. Tay (2008)
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Beifang Ning (2010)
Facile means for quantifying microRNA expression by real-time PCR.
Rui Shi (2005)
Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels
R. Fiore (2009)
Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia
A. Dixon-Mciver (2008)
Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene
Miljana Tanić (2012)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
D. Calvisi (2006)
Genomic imprinting at the mammalian Dlk1-Dio3 domain.
S. T. da Rocha (2008)
Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome 14
T. Ogata (2008)
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells
M. Stadtfeld (2010)
JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update
Jan Christian Bryne (2008)
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tomoaki Tanaka (2006)
Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver.
M. Battle (2006)
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.
T. Ueda (2010)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen (2009)
Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells*♦
Lei Liu (2010)
The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
L. Santangelo (2011)
miRBase: microRNA sequences, targets and gene nomenclature
S. Griffiths-Jones (2006)
Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis
F. Parviz (2003)
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Leonidas Benetatos (2012)
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Yvonne Tay (2009)
Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.
Natalia L. Lazarevich (2004)
This paper is referenced by
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS
Zhi-Liang Wang (2018)
MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway
Yuguang Zhao (2016)
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
Bai-Nan Zheng (2019)
Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.
R. Pan (2015)
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1
Chen-Hong Ding (2018)
A forward genetics approach to identify molecular drivers of liver cancer using Sleeping Beauty mouse models
Jesse D. Riordan (2013)
HDAC9/miR-376a feed-forward loop drive tumorigenesis in hepatocellular carcinoma
Yongxia Zheng (2015)
An integrated approach for the identification of USF1-centered transcriptional regulatory networks during liver regeneration.
Huan Chen (2014)
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
Xiaomei Su (2017)
MicroRNA-134 inhibits HCC cell growth and migration through the AKT / GSK 3 β / SNAIL signaling pathway
Shi-hai Liu (2016)
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Keith. O'Brien (2015)
Hepatocellular Carcinoma: Basic and Transitional Research
Chuan Yin (2014)
Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ
Shota Sasaki (2018)
MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A.
C. F. Chang (2017)
Predictive Toxicology: Genetics, Genomics, Epigenetics, and Next‐Generation Sequencing in Toxicology
Tobias Heckel (2014)
Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
B. Zhang (2017)
Differentiation therapy for solid tumors.
Wen ping Xu (2014)
LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Yong-peng Wei (2020)
Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha
Hong Lu (2017)
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Liang-zhi Wen (2018)
An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function
Aoi Morimoto (2017)
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
Yongtao Gao (2015)
miR‐542‐3p prevents ovariectomy‐induced osteoporosis in rats via targeting SFRP1
Xiguang Zhang (2018)
MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.
Hua Wang (2014)
Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
Meiping Wang (2017)
miR-106b-5p and miR-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation.
Tao Fang (2016)
Regulation of hepatocyte identity and quiescence
Carmen Berasain (2015)
miR-145 suppresses osteogenic differentiation by targeting Sp7.
Jie Jia (2013)
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Feng Rong Fang (2015)
Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients
Yu Wang (2017)
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-ping Xu (2019)See more